-+ 0.00%
-+ 0.00%
-+ 0.00%

BRISTOL-MYERS SQUIBB COMPANY - IZA-BREN REDUCES RISK OF PROGRESSION OR DEATH BY 59% IN PHASE 3 BREAST CANCER STUDY

Reuters·10/23/2026 11:30:00

Please log in to view news